...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Gasoline

Thanks SF I did not miss any of your points in my model. You do know that the current trial is not blinded and the company gets weekly data sets frim the trial operators.

tada

Share
New Message
Please login to post a reply